Marksans Pharma Limited (NSE:MARKSANS)
India · Delayed Price · Currency is INR 321.60
-8.10 (-2.46%)
Aug 31, 2026, 3:29 PM IST
Marksans Pharma Market Cap
Marksans Pharma has a market cap or net worth of 145.74 billion as of August 31, 2026. Its market cap has increased by 90.75% in one year.
Market Cap
145.74B
Enterprise Value
139.56B
Revenue
31.72B
Ranking
n/a
PE Ratio
28.22
Stock Price
321.60
ChartMarket Cap Chart
Since December 13, 2006, Marksans Pharma's market cap has increased from 3.65B to 145.74B, an increase of 3,891.10%. That is a compound annual growth rate of 20.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 145.74B | 78.38% |
| Dec 31, 2025 | 81.70B | -39.22% |
| Dec 31, 2024 | 134.43B | 84.14% |
| Dec 29, 2023 | 73.00B | 210.96% |
| Dec 30, 2022 | 23.48B | -4.66% |
| Dec 31, 2021 | 24.63B | -0.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.61T |
| Divi's Laboratories | 2.45T |
| Apollo Hospitals Enterprise | 1.27T |
| Zydus Lifesciences | 1.19T |
| Syngene International | 160.59B |
| Alembic Pharmaceuticals | 159.89B |
| Concord Biotech | 154.95B |
| NATCO Pharma | 152.92B |